Pharma channel feed – Endpoints News

Pharma channel feed

Updated: Merck temporarily pauses Gardasil shipments to China following sales slowdown

3 months ago

US biosimilar 'void' spells trouble as biologic patent expirations loom, IQVIA report says

3 months ago

Updated: Drug prices likely to soar due to Trump tariffs, pharma bodies warn

3 months ago

J&J’s Rybrevant gets CHMP backing weeks after FDA rejection

3 months ago

Pfizer says new colorectal cancer data could support full approval of Braftovi

3 months ago

AbbVie executives bask in Skyrizi, Rinvoq successes as the drugs take up Humira's mantle

3 months ago

Genentech joins suits against STD clinics it says get 'unlawful' 340B discounts

3 months ago

After more deliberation, England agrees to pay for Vertex’s gene therapy for sickle cell disease

3 months ago

AstraZeneca scraps UK vaccine site expansion after government budget cuts

3 months ago

Celltrion looks to buy US facilities to sidestep potential Trump tariffs

3 months ago

AbbVie raises Skyrizi and Rinvoq estimates, predicts $31B in 2027 sales

3 months ago

Updated: Novartis claims best earnings in years, validating shift to pure-play strategy

3 months ago

Vertex's non-opioid pain drug is approved by FDA, bringing first of new class to market

3 months ago

Regeneron wins appeals court orders backing halt on Eylea biosimilars

3 months ago

FDA approves Axsome's acute migraine treatment after 2022 rejection

3 months ago

Takeda scraps programs as it raises full-year guidance

3 months ago

Takeda CEO Christophe Weber to retire in June 2026, Julie Kim to take over

3 months ago

Sanofi is in the market for M&A, thanks to ‘strong’ balance sheet

3 months ago

Teva CEO says Austedo can grow 'way beyond' impact of IRA

3 months ago

Trump administration makes first comments on how it will run IRA drug negotiations

3 months ago

Key GOP senator is ‘struggling’ with Kennedy nomination over vaccine answers

3 months ago

Ahead of earnings, Lilly culls mid-stage drug for heart failure and chronic kidney disease

3 months ago

AstraZeneca and Daiichi Sankyo's Enhertu approved in 'ultralow' HER2 patients

3 months ago

Ozempic label expanded to include reduced risk of worsening kidney disease

3 months ago

First page Previous page 15 16 171819 20 21 Next page Last page